3.00
-1.05 (-25.93%)
-1.05 (-25.93%)
Upgrade to Real-Time
Market Open
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CytoDyn Inc (QB) | CYDY | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -1.05 | -25.93% | 3.00 | 14:03:13 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.90 | 2.70 | 3.28 | 4.05 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.00 | 3.01 | 0.01 | - | 2 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,779 | 16,960,368 | $ 3.0311 | $ 51,408,146 | - | 0.81 - 10.01 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:03:30 | 22 | $ 3.00 | USD |
CytoDyn (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.83B | 608.65M | 377.49M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 21.61M | $ - | 0.00% | - | - |
CytoDyn (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYDY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.51 | 5.05 | 2.70 | 4.23 | 2,812,757 | -1.51 | -33.48% |
| 1 Month | 6.23 | 7.70 | 2.70 | 4.95 | 3,846,799 | -3.23 | -51.85% |
| 3 Months | 3.17 | 7.70 | 2.70 | 5.28 | 5,061,219 | -0.17 | -5.36% |
| 6 Months | 4.81 | 7.70 | 1.63 | 4.29 | 4,093,034 | -1.81 | -37.63% |
| 1 Year | 1.15 | 10.01 | 0.81 | 4.03 | 5,805,617 | 1.85 | 160.87% |
| 3 Years | 0.7345 | 10.01 | 0.0552 | 3.32 | 2,485,105 | 2.27 | 308.44% |
| 5 Years | 0.81 | 10.01 | 0.0552 | 3.17 | 1,589,963 | 2.19 | 270.37% |
CytoDyn (QB) Description
| CytoDyn Inc. is a late-stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of Human Immunodeficiency Virus (HIV), Cancer, and Immunology. |
